Uso de Metilergonovina en puérperas Hospital de Apoyo II IPSS Tarapoto - 1994

• Autores: Romero Mendo, Digna, Méndez Podesta, Luz Mercedes
• Formato: tesis de grado
• Fecha de Publicación: 1995
• Institución: Universidad Nacional de San Martin - Tarapoto
• Repositorio: UNSM-Institucional
• Lenguaje: español
• OAI Identifier: oai:repositorio.unsm.edu.pe:11458/1309
• Enlace del recurso: http://hdl.handle.net/11458/1309
• Nivel de acceso: acceso abierto
• Materia: Uso de ciertas drogas; Hemorragias; Utilidad clínica de la Metilergonovina

The immediate postpartum comprises a critical phase of the reproductive period of women, leading to the use of certain drugs that cause a number of complications (especially bleeding) that may occur in this period, in order to determine the average volume blood loss and clinical utility of methylergonovine. In the service of Gynecology and Obstetrics Hospital Support II IPSS Tarapoto in the year 1994, a basic experimental study with prospective data connection was made, a total of 300 postpartum patients divided into two groups each consisting of 150 postpartum women; one of the (experimental) group were administered 0.2 mg Methylergonovine. I. M. the delivery of the placenta and 0.125 mg. Every 8 hours V.O. for three consecutive days delivery. The other group received no encouragement, after the testing of the hypothesis and the respective analysis determined that the average value of blood loss during the first 12 hours was 305.32 ml., Being higher in the control group (they received methylergonovine) bringing the clinical utility of reinforced methylergonovine but statistically found that bleeding is independent of methylergonovine